Czechia· CZ-0185942
LAMPRENE
A clofazimine product containing clofazimine, registered in Czechia. The same ATC class is registered in 7 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Clofazimine is registered in 7 of 19 countries.
Countries holding a registration under ATC J04BA01 (clofazimine), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Clofazimine · ATC J04BA01
7 / 19 countries
- Czechiaprice
- Franceprice
- Japan
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- CLOFAZIMINE
- Manufacturer
- —
- Country
- Czechia (CZ)
- ATC code
- J04BA01
- ATC class
- Clofazimine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
158 interactions on record for clofazimine.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clofazimine · interactions on record
158 records
- 37 severe
- 119 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PapaverinC04AX38severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clofazimine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLampreneNovartis Pharmaceuticals Corporation
- FranceLAMPRENE 50 mg, capsule molleNOVARTIS PHARMA
- NorwayLampreneNovartis
- United KingdomClofazimine 100mg capsulesSpecial Order
- SpainLAMPREN CAPSULASNovartis Farmaceutica S.A.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- France · Lamprene
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3b76a45b-474c-49f2-87c9-3c8e2e1e9dd5 GET /v1/drugs/3b76a45b-474c-49f2-87c9-3c8e2e1e9dd5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CPS MOL",
"source": "sukl",
"strength": "50MG",
"pack_size": "100",
"substance": "CLOFAZIMINE",
"cz_kod_sukl": "0185942",
"product_type": "CH",
"substance_codes": "6838",
"registration_state": "F",
"registration_number": null
}See everything about clofazimine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.